Tirzepatide has been studied in two massive clinical trial programs, SURPASS for type 2 diabetes and SURMOUNT for weight management, collectively enrolling tens of thousands of participants across multiple countries and treatment durations
As more is learned from this pilot, the team hopes to expand the use of this technology in patient-facing settings such as labor and delivery rooms or emergency department waiting areas
Patients using or considering compounded semaglutide or tirzepatide should not substitute allulose as a replacement, as the clinical efficacy and magnitude of effect are fundamentally different
All model parameters were assumed log-normally distributed
IL-2 is downregulated, along with other markers for CD8+ T cell exhaustion, in some ME/CFS patients
If a reconstituted vial froze solid, discard it